Form 4 for ATOS ATOSSA THERAPEUTICS, INC.
Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-26 · accession 0000950170-25-046742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-28 | 2025-03-26 | ATOS | Remmel H. Lawrence | Dir | P - Purchase | $0.7 | +10.0K | 10.3K | +3,891% | +$7,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-26 | P | A | 10,000 | $0.7 | 10,257 | D | — | — | (F1) Reflects a reverse stock split of the Issuer's common stock at a ratio of 12:1 effective April 2018. The Reporting Person disclaims beneficial ownership of 11 shares of common stock owned by his spouse except to the extent of his pecuniary interest in the shares. |